Copyright © 1988 by the European Society of Cardiology.
© 1988 The European Society of Cardiology
Dilitiazem in Comparison with metoprolol in stable angina pectoris
Department of Cadiology(Thoraxcentre),University Hospital Groningen Oostersingel 59,9713 EZ Groningen,The Netherlands
Received 7 October 1987; revised 5 April 1988; .
René B. van Dijk, Thoraxcentre, University Hospital Groningen, Oostersingel 59, 9713 EZ Groningen. The Netherlands.
Abstract
The efficacy of diltiazem in comparison with metoprolol in chornic stable angina was asessted in 33 male patients during a 15-week blind cross-over study. After an initial two-week run-in period, baseline measuremens were made. Subsequently,the patients enered a cross-over study consisting of two six-week treatment periods with diltiazem 240 mg (60 mg q.i.d.)or metoprol 200 mg (100 mg b.i.d.).Dose adjustment to either 360 mg diltiazem(120t.i.d.)or 400 mg metoprolol(200b.i.d.)was allowed two weeks after the start of treatment. There was a one-week washout period between the two treatment periods.
Compared to baseline values both drugs reduced the number of anginal attacks (diltiazem 55%,p=0.02; metoprolol 73%,P=0.01)and showed improvement of the measured exercise variables(exercise duration; diltiazem +16%,P<0.001;meoprolol +4%,P=NS; time to angina:diltiazem +21%,P=0.02,metoprolol + 14%, P =NS;maximal ST-depression: diltiazem +13%,P =NS,metoprolol +33%,P=0.002).No significant change in LVEF was noticed.Both drugs reduced the mean heart rate on Holter tape (diltiazem11%,P=0.006;metoprolol 14%, P=0.004). No effects on conduction were noticed.
Although at the borderline of significance, diltiazem increased the total exercise duration as compared to metoprolol (16 vs, 4%,P=0.05). It is concluded that diltiazem improves exercise tolerance in patients with stable angina pectoris and appears to be a safe and effective alternative to the beta-blocking agent metoprolol.Our findings underscore the value of diltiazem as a monotherapeutic drug for the treatment of stable angina.
Key Words: Angina pectoris, diltiazem, metoprolol, calcium antagonists, beta blockers.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
![]() |
P. A. Heidenreich, K. M. McDonald, T. Hastie, B. Fadel, V. Hagan, B. K. Lee, and M. A. Hlatky Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina JAMA, May 26, 1999; 281(20): 1927 - 1936. [Abstract] [Full Text] [PDF] |
||||

